drugset / Trial / NCT04679948
A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood
NaSingle-groupOpen-labelTreatment
Summary
The trial will be performed to assess the influence of BI 730357 on the pharmacokinetics of caffeine, warfarin, omeprazole and midazolam.
Timeline
- Start
- 2020-12-21
- Primary completion
- 2021-03-17
- Completion
- 2021-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Antra MUPS® | Unknown | — | Oral |
| Subject | BI 730357 | Unknown | — | — |
| Subject | Midazolam-ratiopharm® | Unknown | — | Oral |
| Subject | Percoffedrinol® | Unknown | — | Oral |
| Subject | Warfarin | Small molecule | — | Oral |
Indications
No indication recorded.